Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011 (2011), Article ID 895471, 7 pages
http://dx.doi.org/10.1155/2011/895471
Research Article

Effects of Vitamin D Plus Calcium Supplements on Pharmacokinetics of Isoflavones in Thai Postmenopausal Women

1Department of Pharmacology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
2Center of Thai Traditional and Complementary Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand

Received 23 September 2010; Accepted 14 February 2011

Copyright © 2011 Supanimit Teekachunhatean et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Blake, “Menopause: evidence-based practice,” Best Practice and Research: Clinical Obstetrics and Gynaecology, vol. 20, no. 6, pp. 799–839, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Al-Azzawi, “The menopause and its treatment in perspective,” Postgraduate Medical Journal, vol. 77, no. 907, pp. 292–304, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Hickey, S. R. Davis, and D. W. Sturdee, “Treatment of menopausal symptoms: what shall we do now?” The Lancet, vol. 366, no. 9483, pp. 409–421, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Grady, T. Gebretsadik, K. Kerlikowske, V. Ernster, and D. Petitti, “Hormone replacement therapy and endometrial cancer risk: a meta-analysis,” Obstetrics and Gynecology, vol. 85, no. 2, pp. 304–313, 1995. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Wells, D. W. Sturdee, D. H. Barlow et al., “Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study,” British Medical Journal, vol. 325, no. 7358, pp. 239–242, 2002. View at Google Scholar · View at Scopus
  6. J. E. Rossouw, G. L. Anderson, R. L. Prentice et al., “Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial,” Journal of the American Medical Association, vol. 288, no. 3, pp. 321–333, 2002. View at Google Scholar · View at Scopus
  7. K. D. Setchell, “Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones,” American Journal of Clinical Nutrition, Supplement, vol. 68, no. 6, pp. 1333–1346, 1998. View at Google Scholar
  8. H. A. Philp, “Hot flashes—a review of the literature on alternative and complementary treatment approaches,” Alternative Medicine Review, vol. 8, no. 3, pp. 284–302, 2003. View at Google Scholar · View at Scopus
  9. D. L. Alekel, A. S. Germain, C. T. Peterson, K. B. Hanson, J. W. Stewart, and T. Toda, “Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women,” American Journal of Clinical Nutrition, vol. 72, no. 3, pp. 844–852, 2000. View at Google Scholar · View at Scopus
  10. S. M. Potter, J. A. Baum, H. Teng et al., “Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women,” American Journal of Clinical Nutrition, Supplement, vol. 68, no. 6, pp. 1375–1379, 1998. View at Google Scholar
  11. E. M. Lewiecki, “Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis,” Journal of Women's Health, vol. 18, no. 10, pp. 1615–1626, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. G. Sweet, J. M. Sweet, M. P. Jeremiah, and S. S. Galazka, “Diagnosis and treatment of osteoporosis,” American Family Physician, vol. 79, no. 3, pp. 193–202, 2009. View at Google Scholar · View at Scopus
  13. H. A. Bischoff-Ferrari, W. C. Willett, J. B. Wong, E. Giovannucci, T. Dietrich, and B. Dawson-Hughes, “Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials,” Journal of the American Medical Association, vol. 293, no. 18, pp. 2257–2264, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Boonen, P. Lips, R. Bouillon, H. A. Bischoff-Ferrari, D. Vanderschueren, and P. Haentjens, “Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 4, pp. 1415–1423, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. B. F. Thomas, S. H. Zeisel, M. G. Busby et al., “Quantitative analysis of the principle soy isoflavones genistein, daidzein and glycitein, and their primary conjugated metabolites in human plasma and urine using reversed-phase high-performance liquid chromatography with ultraviolet detection,” Journal of Chromatography B, vol. 760, no. 2, pp. 191–205, 2001. View at Google Scholar
  16. H. J. Wang and P. A. Murphy, “Isoflavone content in commercial soybean foods,” Journal of Agricultural and Food Chemistry, vol. 42, no. 8, pp. 1666–1673, 1994. View at Google Scholar · View at Scopus
  17. L. Coward, M. Kirk, N. Albin, and S. Barnes, “Analysis of plasma isoflavones by reversed-phase HPLC-multiple reaction ion monitoring-mass spectrometry,” Clinica Chimica Acta, vol. 247, no. 1-2, pp. 121–142, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. K. D. R. Setchell, N. M. Brown, P. Desai et al., “Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements,” Journal of Nutrition, vol. 131, no. 4, pp. 1362–1375, 2001. View at Google Scholar · View at Scopus
  19. S. Watanabe, M. Yamaguchi, T. Sobue et al., “Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako),” Journal of Nutrition, vol. 128, no. 10, pp. 1710–1715, 1998. View at Google Scholar · View at Scopus
  20. S. Vergne, K. Titier, V. Bernard et al., “Bioavailability and urinary excretion of isoflavones in humans: effects of soy-based supplements formulation and equol production,” Journal of Pharmaceutical and Biomedical Analysis, vol. 43, no. 4, pp. 1488–1494, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Rowland, M. Faughnan, L. Hoey, K. Wähälä, G. Williamson, and A. Cassidy, “Bioavailability of phyto-oestrogens,” British Journal of Nutrition, vol. 89, no. 1, pp. S45–S58, 2003. View at Google Scholar · View at Scopus
  22. A. J. Daya, M. S. DuPont, S. Ridley et al., “Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity,” Federation European biochemical Societies Letter, vol. 436, no. 1, pp. 71–75, 1998. View at Google Scholar
  23. P. W. Parodi, “The role of intestinal bacteria in the causation and prevention of cancer: modulation by diet and probiotics,” Australian Journal of Dairy Technology, vol. 54, no. 2, pp. 103–121, 1999. View at Google Scholar · View at Scopus
  24. E. Anupongsanugool, S. Teekachunhatean, N. Rojanasthien, S. Pongsatha, and C. Sangdee, “Pharmacokinetics of isoflavones, daidzein and genistein, after ingestion of soy beverage compared with soy extract capsules in postmenopausal Thai women,” BMC Clinical Pharmacology, vol. 5, article 2, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Foti, D. Erba, A. Spadafranca, S. Ciappellano, J. Bresciani, and G. Testolin, “Daidzein is absorbed by passive transport in isolated small intestine of rats,” Nutrition Research, vol. 26, no. 6, pp. 284–288, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. K. D. R. Setchell, N. Maynard Brown, P. B. Desai et al., “Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes,” Journal of Nutrition, vol. 133, no. 4, pp. 1027–1035, 2003. View at Google Scholar · View at Scopus
  27. D. A. Straub, “Calcium supplementation in clinical practice: a review of forms, doses, and indications,” Nutrition in Clinical Practice, vol. 22, no. 3, pp. 286–296, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. S. Faughnan, A. Hawdon, E. Ah-Singh, J. Brown, D. J. Millward, and A. Cassidy, “Urinary isoflavone kinetics: the effect of age, gender, food matrix and chemical composition,” British Journal of Nutrition, vol. 91, no. 4, pp. 567–574, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. H. L. McLeod, “Pharmacokinetics for the prescriber,” Medicine, vol. 31, no. 8, pp. 11–15, 2003. View at Google Scholar · View at Scopus